Interpace Diagnostics
Highly Engaged Employees
Healthcare Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
300 Interpace Pkwy Bldg C, Parsippany, N...Phone Number
(855) 776-6419Website
www.interpacediagnostics.comRevenue
$13.8 MillionIndustry
About Interpace Diagnostics
Interpace Diagnostics Group, Inc. develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its proprietary PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. Its customers consist primarily of physicians, hospitals, and clinics. The company was formerly known as PDI, Inc. and changed its name to Interpace Diagnostics Group, Inc. in December 2015. Interpace Diagnostics Group, Inc. was incorporated in 1986 and is headquartered in Parsippany, New...Explore more
SIC Code 80,807NAICS Code 62,621Show moreInterpace Diagnostics Org Chart
Interpace Diagnostics Tech Stack
A closer look at the technologies used by Interpace Diagnostics
Top Healthcare Services Companies
Frequently Asked Questions Regarding Interpace Diagnostics
Sign Up For FreeTo access detailed company insights
Interpace Diagnostics Group, Inc. develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic... Read More